Ohio Chapter of GAPNA

The ITP Expert Exchange: Translating Evidence Into Evolving Practice

Webinar/Online

Friday, January 9, 2026 at 2:00pm ET - 3:00pm ET
Add this event to your calendar

Info

Topic

Discover what's next in innovation and evidence, and transform your immune thrombocytopenia (ITP) care by attending this live expert exchange webinar. New insights into ITP are opening the door to treatments that go beyond platelet counts to address the symptoms that truly affect patients' lives. Join leading experts for an interactive, case-driven webinar exploring the latest breakthroughs in ITP management. You'll uncover the science behind new and emerging therapies, understand how they target key mechanisms of disease, and see how they may help close the gap in treating fatigue, cognitive impairment, and other quality-of-life challenges faced by patients every day. Don't miss your chance to stay ahead of the curve. Gain early access to the most recent clinical trial results on safety, efficacy, and patient-reported outcomes, and hear expert perspectives on integrating these therapies into practice across treatment lines. Whether you're a hematologist, pharmacist, nurse, or member of a multidisciplinary care team, this session will give you the tools and insights to elevate care for patients with ITP.

Credits Offered

This event offers 0.75 contact hours to attendees.
Accreditation Info: AANP.

Additional Information

Discover what's next in innovation and evidence, and transform your immune thrombocytopenia (ITP) care by attending this live expert exchange webinar.

Speakers

Cindy Neunert
Cindy Neunert MD MSCS

Dr. Cindy Neunert is a Professor of Pediatrics at Columbia University in New York. She received fellowship training in Pediatric Hematology-Oncology at University of Texas Southwestern Medical School at Dallas in Texas where she also obtained her Master’s degree in clinical research. Her research interests involve assessing patient-related outcomes in disorders of hemostasis and thrombosis. She was chair of the of the 2019 American Society of Hematology guidelines on the diagnosis and management of Immune Thrombocytopenia. She works closely with the Intercontinental Cooperative ITP Study Group and is the former chair of the Pediatric ITP Consortium of North America. ACTIVITY AFFILIATIONS January 9, 2026 The ITP Expert Exchange: Translating Evidence Into Evolving Practice May 29, 2025 Examining the Latest Clinical Evidence on Thrombopoietin Receptor Agonists for Treatment of Pediatric Immune Thrombocytopenia May 29, 2025 Expert Strategies to Address Challenges in the Treatment and Management of Pediatric Immune Thrombocytopenia May 29, 2025 The Future of Immune Thrombocytopenia Treatment: Emerging Evidence and Clinical Implications for Thrombopoietin Receptor Agonists

Hanny Al-Samkari
Hanny Al-Samkari MD

Classical Hematologist and Clinical Investigator
The Peggy S. Blitz Endowed Chair in Hematology/Oncology
Co-Director, Hereditary Hemorrhagic Telangiectasia Center
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School

Dr. Hanny Al-Samkari is the Peggy S. Blitz Endowed Chair in Hematology/Oncology at the Massachusetts General Hospital and an Associate Professor of Medicine at Harvard Medical School. He is a classical hematologist and NIH-funded clinical investigator and clinical trialist. He also serves as Co-Director the MGH Hereditary Hemorrhagic Telangiectasia (HHT) Center of Excellence. His clinical and research interests are in hemostasis, thrombosis and hemolysis, with focuses in HHT, immune thrombocytopenia, and hemolytic anemias. As a clinical investigator, Dr. Al-Samkari is an internationally recognized expert in the clinical development of novel therapeutics for these disorders and serves as the lead principal investigator for multiple ongoing clinical trials. He is the emeritus Executive Editor of Hematology: The American Society of Hematology Education Program, and a current Associate Editor of the Journal of Thrombosis and Haemostasis, the flagship journal of the International Society on Thrombosis and Haemostasis. He has published over 180 peer-reviewed manuscripts. His original research has been featured in The New England Journal of Medicine, The Lancet, Annals of Internal Medicine and Blood, among other top peer-reviewed journals in hematology and medicine. ACTIVITY AFFILIATIONS January 9, 2026 The ITP Expert Exchange: Translating Evidence Into Evolving Practice

Douglas S Burgoyne
Douglas S Burgoyne PharmD, FAMCP

Adjunct Professor
Department of Pharmacotherapy
University of Utah College of Pharmacy
Salt Lake City, UT

Interested In Attending This Event?